These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30132406)

  • 1. Hyperthyroidism and Papillary Thyroid Carcinoma in Thyrotropin Receptor D633H Mutant Mice.
    Jaeschke H; Undeutsch H; Patyra K; Löf C; Eszlinger M; Khalil M; Jännäri M; Makkonen K; Toppari J; Zhang FP; Poutanen M; Paschke R; Kero J
    Thyroid; 2018 Oct; 28(10):1372-1386. PubMed ID: 30132406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of mitogen-activated protein kinase signaling and development of papillary thyroid carcinoma in thyroid-stimulating hormone receptor D633H knockin mice.
    Eszlinger M; Stephenson A; Mirhadi S; Patyra K; Moran MF; Khalil M; Kero J; Paschke R
    Eur Thyroid J; 2023 Dec; 12(6):. PubMed ID: 37855416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes.
    Ruggeri RM; Campennì A; Giovinazzo S; Saraceno G; Vicchio TM; Carlotta D; Cucinotta MP; Micali C; Trimarchi F; Tuccari G; Baldari S; Benvenga S
    Thyroid; 2013 Feb; 23(2):239-42. PubMed ID: 22985488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.
    Nishihara E; Chen CR; Higashiyama T; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
    Thyroid; 2010 Nov; 20(11):1307-14. PubMed ID: 20929407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.
    Aycan Z; Ağladıoğlu SY; Ceylaner S; Cetinkaya S; Baş VN; Kendirici HN
    J Clin Res Pediatr Endocrinol; 2010; 2(4):168-72. PubMed ID: 21274318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism.
    Gozu HI; Lublinghoff J; Bircan R; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):125-34. PubMed ID: 20138963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
    Jaeschke H; Mueller S; Eszlinger M; Paschke R
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
    Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
    Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R).
    Pohlenz J; Pfarr N; Krüger S; Hesse V
    Acta Paediatr; 2006 Dec; 95(12):1685-7. PubMed ID: 17129985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
    Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy.
    Bertalan R; Sallai A; Sólyom J; Lotz G; Szabó I; Kovács B; Szabó E; Patócs A; Rácz K
    Thyroid; 2010 Mar; 20(3):327-32. PubMed ID: 20146656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
    Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
    Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism.
    Nishihara E; Nagayama Y; Amino N; Hishinuma A; Takano T; Yoshida H; Kubota S; Fukata S; Kuma K; Miyauchi A
    Endocr J; 2007 Dec; 54(6):927-34. PubMed ID: 18025759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].
    Derwahl M
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.
    Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M
    Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TSHR rs2288496 associated with thyroid hormone and predict the occurrence of lymph node metastasis of papillary thyroid cancer.
    Su X; Lin LW; Weng JL; Chen SW; Yang XH; Zhou DL; Long YK; Shao Q; Ye ZL; Peng JL; Deng L; He CY; Yang AK
    Cancer Biomark; 2019; 26(4):461-470. PubMed ID: 31658048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
    Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable phenotype associated with Ser505Asn-activating thyrotropin-receptor germline mutation.
    Führer D; Mix M; Wonerow P; Richter I; Willgerodt H; Paschke R
    Thyroid; 1999 Aug; 9(8):757-61. PubMed ID: 10482366
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.